June 29, 2017 / 11:03 AM / 4 months ago

BUZZ-Valeant Pharmaceuticals: FDA accepts bowel cleanser drug application

** Canadian drugmaker’s U.S.-listed shares up 4.78 pct at $17.97 premarket

** FDA accepts unit Salix Pharmaceuticals’ marketing application for bowel cleanser drug, Plenvu

** Plenvu licensed from European specialist pharmaceutical company Norgine BV

** Colorectal cancer, also known as bowel cancer, is the third leading cause of cancer-related deaths in women in the United States and the second leading cause in men

** Up to Wednesday’s close, stock had risen about 42 pct this month; up 18.11 pct YTD

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below